TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damage.
Cunningham, D
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damage. [electronic resource] - Medical oncology and tumor pharmacotherapy 1986 - 25-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0736-0118
10.1007/BF02934572 doi
Acetylglucosaminidase--urine
Adenocarcinoma--drug therapy
Colonic Neoplasms--drug therapy
Female
Humans
Kidney Diseases--chemically induced
Male
Middle Aged
Organoplatinum Compounds--adverse effects
Rectal Neoplasms--drug therapy
Stomach Neoplasms--drug therapy
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damage. [electronic resource] - Medical oncology and tumor pharmacotherapy 1986 - 25-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0736-0118
10.1007/BF02934572 doi
Acetylglucosaminidase--urine
Adenocarcinoma--drug therapy
Colonic Neoplasms--drug therapy
Female
Humans
Kidney Diseases--chemically induced
Male
Middle Aged
Organoplatinum Compounds--adverse effects
Rectal Neoplasms--drug therapy
Stomach Neoplasms--drug therapy